Sanifit appoints Cris Calsada as CFO
Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the appointment of Cris Calsada as Chief Financial Officer.
Ms. Calsada joins Sanifit with over 20 years of corporate finance and executive experience in the life sciences and technology industries. She was most recently COO and VP of Finance at Ambrx where she led the companys finance organization during its Series A financing completed in 2005 through its acquisition in 2015.
Commenting on the new appointment, Joan Perelló, CEO of Sanifit said, We are excited to welcome Cris to our senior leadership team, her strong leadership and first-hand expertise in the financial and strategic operations of clinical stage therapeutics development will be instrumental as we grow our business and advance our pipeline.
Sanifit is currently conducting a phase IIb study in ESRD patients and conducting the orphan-designated development program in calciphylaxis.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium